Effects of chronic inhibition of Testosterone metabolism on cardiac remodeling after ischemia/reperfusion-induced myocardial damage in gonadectomized rats.

17β-estradiol Cardiac remodeling Cardio-protection Metalloproteinase Testosterone

Journal

Biology open
ISSN: 2046-6390
Titre abrégé: Biol Open
Pays: England
ID NLM: 101578018

Informations de publication

Date de publication:
13 May 2019
Historique:
entrez: 16 5 2019
pubmed: 16 5 2019
medline: 16 5 2019
Statut: epublish

Résumé

The effects of testosterone on cardiovascular homeostasis are still not well understood. The objective of this work was to evaluate the effects of testosterone in the absence or presence of inhibition of Aromatase (4-hydroxyandrostenedione) and/or 5α reductase (Finasteride) enzymatic activities on the myocardial remodeling 30 days after ischemia/reperfusion (I/R) injury in gonadectomized rats. Results showed that testosterone administration to ORX rats resulted in decreased myocardial damaged area, inflammatory infiltrates and reduced MMP-3 and 13 expressions. Interestingly, Finasteride administration resulted in a greater decrease in scar tissue, inflammatory infiltrates, along with a significant decrease in MMP-3 and 13 expressions. In contrast, 4-hydroxyandrostenedione administrations increased all parameters. Our results suggest that testosterone does not have a direct effect since simultaneous inhibition of aromatase and 5α-reductase did not induce significant changes in I/R induced myocardial injury.

Identifiants

pubmed: 31085546
pii: bio.041905
doi: 10.1242/bio.041905
pmc: PMC6550079
pii:
doi:

Types de publication

Journal Article

Langues

eng

Informations de copyright

© 2019. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interestsDr Ceballos is a stockholder of Cardero Therapeutics, Inc., all rest of the authors state that they do not have any financial or other relationships that might lead to a conflict of interest.

Références

Circulation. 1999 Jun 15;99(23):3063-70
pubmed: 10368126
Cardiovasc Res. 2000 May;46(2):298-306
pubmed: 10773234
J Clin Invest. 2000 Jun;105(11):1519-20
pubmed: 10841508
Pharmacol Biochem Behav. 2000 Nov;67(3):613-20
pubmed: 11164093
Life Sci. 2001 Jan 5;68(7):799-814
pubmed: 11205871
Circ Res. 2002 Feb 22;90(3):251-62
pubmed: 11861412
Circ Res. 2002 Mar 22;90(5):520-30
pubmed: 11909815
Am J Physiol Endocrinol Metab. 2003 Sep;285(3):E449-53
pubmed: 12684218
Endocrinology. 2003 Oct;144(10):4478-83
pubmed: 12960063
Circulation. 2004 May 4;109(17):2143-9
pubmed: 15051632
Am J Physiol Heart Circ Physiol. 2005 Jan;288(1):H221-6
pubmed: 15374831
Circulation. 2004 Nov 9;110(19):3100-7
pubmed: 15520315
Cardiovasc Res. 2005 May 1;66(2):410-9
pubmed: 15820210
J Mol Cell Cardiol. 2005 Aug;39(2):259-68
pubmed: 15893322
Endocrinology. 2006 Oct;147(10):4569-77
pubmed: 16794012
Can J Physiol Pharmacol. 2006 Jan;84(1):93-109
pubmed: 16845894
Circulation. 2006 Sep 5;114(10):1020-7
pubmed: 16923753
Arch Intern Med. 2007 Jun 25;167(12):1252-60
pubmed: 17592098
Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3575-83
pubmed: 17906098
Physiol Rev. 2007 Oct;87(4):1285-342
pubmed: 17928585
Eur J Heart Fail. 2008 Feb;10(2):133-9
pubmed: 18234553
Cardiovasc Toxicol. 2008 Fall;8(3):101-13
pubmed: 18683081
Annu Rev Physiol. 2009;71:1-18
pubmed: 18828746
Exp Toxicol Pathol. 2009 Jul;61(4):317-23
pubmed: 19027274
Int J Cardiol. 2010 Sep 3;143(3):343-8
pubmed: 19395096
J Biol Chem. 2009 Jul 24;284(30):19786-90
pubmed: 19515843
Kidney Blood Press Res. 2009;32(3):175-84
pubmed: 19521107
Exp Biol Med (Maywood). 2009 Sep;234(9):1011-9
pubmed: 19546346
Endokrynol Pol. 2010 Jan-Feb;61(1):126-34
pubmed: 20205115
J Clin Endocrinol Metab. 2010 Aug;95(8):3955-64
pubmed: 20534765
Circ Heart Fail. 2010 Jul;3(4):470-1
pubmed: 20647488
Heart. 2010 Nov;96(22):1821-5
pubmed: 20959649
Circ Heart Fail. 2011 May;4(3):246-56
pubmed: 21350055
J Sex Med. 2012 Jan;9(1):54-67
pubmed: 21676183
Neth Heart J. 2011 Jan;19(1):1-2
pubmed: 22020853
Circulation. 2012 Jun 19;125(24):2993-3003
pubmed: 22610965
Handb Exp Pharmacol. 2012;(214):3-22
pubmed: 23027443
Steroids. 2013 Mar;78(3):362-9
pubmed: 23276633
Pflugers Arch. 2013 May;465(5):747-63
pubmed: 23417603
Am J Cardiol. 2016 Mar 15;117(6):881-6
pubmed: 26805660
Andrology. 2018 Jan;6(1):74-85
pubmed: 29194990
Asian J Androl. 2018 Mar-Apr;20(2):120-130
pubmed: 29442075
Arterioscler Thromb. 1994 May;14(5):701-6
pubmed: 8172848
Cancer Lett. 1996 Mar 29;101(2):143-8
pubmed: 8620462
Biochem J. 1998 Apr 1;331 ( Pt 1):341-6
pubmed: 9512498

Auteurs

Octavio Maldonado (O)

CIB-Doctorado en Ciencias Biomédicas-UV. Centro de Investigaciones Biomédicas, Universidad Veracruzana, Av. Dr. Luis Castelazo Ayala s/n, Colonia Industrial Anima, CP. 91000, Xalapa, Veracruz, Mexico.
Departamento de Nanotecnología, Universidad Tecnológica del Centro de Veracruz, Av. Universidad No. 350, Carretera Federal Cuitláhuac - La Tinaja, Localidad Dos Caminos, CP. 94910, Cuitláhuac, Veracruz, Mexico.

Angel Ramos (A)

MCPB-Facultad de Ciencias Químicas, Universidad Veracruzana, Prolongación Oriente 6, No. 1009, Colonia Rafael Alvarado, CP. 94340, Orizaba, Veracruz, Mexico.

Mario Guapillo (M)

Laboratorio de Biología Molecular, Facultad de Ciencias Químicas, Universidad Veracruzana, Prolongación Oriente 6, No. 1009, Colonia Rafael Alvarado, CP. 94340, Orizaba, Veracruz, Mexico.

Jose Rivera (J)

MCPB-Facultad de Ciencias Químicas, Universidad Veracruzana, Prolongación Oriente 6, No. 1009, Colonia Rafael Alvarado, CP. 94340, Orizaba, Veracruz, Mexico.

Icela Palma (I)

Seccion de Estudios de posgrado, Escuela Superior de Medicina, Instituto Politecnico Nacional, Plan de San Luis y Díaz Mirón, CP. 11340, Ciudad de México, Mexico.

Ivan Rubio-Gayosso (I)

Seccion de Estudios de posgrado, Escuela Superior de Medicina, Instituto Politecnico Nacional, Plan de San Luis y Díaz Mirón, CP. 11340, Ciudad de México, Mexico.

Israel Ramirez-Sanchez (I)

Seccion de Estudios de posgrado, Escuela Superior de Medicina, Instituto Politecnico Nacional, Plan de San Luis y Díaz Mirón, CP. 11340, Ciudad de México, Mexico.

Nayelli Najera (N)

Seccion de Estudios de posgrado, Escuela Superior de Medicina, Instituto Politecnico Nacional, Plan de San Luis y Díaz Mirón, CP. 11340, Ciudad de México, Mexico.

Guillermo Ceballos (G)

Seccion de Estudios de posgrado, Escuela Superior de Medicina, Instituto Politecnico Nacional, Plan de San Luis y Díaz Mirón, CP. 11340, Ciudad de México, Mexico gceballosr@ipn.mx.

Enrique Mendez-Bolaina (E)

CIB-Doctorado en Ciencias Biomédicas-UV. Centro de Investigaciones Biomédicas, Universidad Veracruzana, Av. Dr. Luis Castelazo Ayala s/n, Colonia Industrial Anima, CP. 91000, Xalapa, Veracruz, Mexico.
MCPB-Facultad de Ciencias Químicas, Universidad Veracruzana, Prolongación Oriente 6, No. 1009, Colonia Rafael Alvarado, CP. 94340, Orizaba, Veracruz, Mexico.

Classifications MeSH